SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5obu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.11A	1c8lA-5obuA: undetectable	1c8lA-5obuA: 7.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_1 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 4	THR A 267 LEU A 266 VAL A 276 LEU A 278	None	1.09A	1fbmB-5obuA: undetectable	1fbmB-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FK6_A_LNLA1201_1 (NON-SPECIFIC LIPID TRANSFER PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	ASN A 231 ALA A 238 LEU A 242 ALA A 246 ILE A 216	None	0.76A	1fk6A-5obuA: undetectable	1fk6A-5obuA: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.07A	1gfzA-5obuA: undetectable	1gfzA-5obuA: 7.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.08A	1l5qA-5obuA: undetectable	1l5qA-5obuA: 7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.07A	1l5qB-5obuA: undetectable	1l5qB-5obuA: 7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.03A	1l7xA-5obuA: undetectable	1l7xA-5obuA: 7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.07A	1l7xB-5obuA: undetectable	1l7xB-5obuA: 7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QZZ_A_SAMA635_0 (ACLACINOMYCIN-10-HYD ROXYLASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	GLY A 208 GLY A 180 GLY A 181 LEU A 206 ASN A 213	ANP A 602 (-3.3A) ANP A 602 (-3.4A) ANP A 602 (-3.5A) None None	0.83A	1qzzA-5obuA: 2.4	1qzzA-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RK3_A_VDXA500_1 (VITAMIN D3 RECEPTOR)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 332 VAL A 333 SER A 335 VAL A 185 LEU A 187	None	1.26A	1rk3A-5obuA: undetectable	1rk3A-5obuA: 12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9P_A_DESA459_1 (ESTROGEN-RELATED RECEPTOR GAMMA)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 103 LEU A 106 ALA A 110 LEU A 31 ILE A 123	None	1.02A	1s9pA-5obuA: undetectable	1s9pA-5obuA: 17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9P_D_DESD600_1 (ESTROGEN-RELATED RECEPTOR GAMMA)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 103 LEU A 106 ALA A 110 LEU A 31 ILE A 123	None	1.04A	1s9pD-5obuA: undetectable	1s9pD-5obuA: 17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_B_BAXB1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	3 / 3	ILE A 453 ASP A 418 PHE A 438	None	0.66A	1uwjB-5obuA: undetectable	1uwjB-5obuA: 14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X7P_B_SAMB302_0 (RRNA METHYLTRANSFERASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 10	ASP A 471 GLY A 441 GLY A 442 ILE A 455 LEU A 522	None	1.16A	1x7pA-5obuA: undetectable 1x7pB-5obuA: undetectable	1x7pA-5obuA: undetectable 1x7pB-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XDS_A_SAMA5635_0 (PROTEIN RDMB)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	GLY A 208 GLY A 180 GLY A 181 LEU A 206 ASN A 213	ANP A 602 (-3.3A) ANP A 602 (-3.4A) ANP A 602 (-3.5A) None None	0.91A	1xdsA-5obuA: undetectable	1xdsA-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XDS_B_SAMB9635_0 (PROTEIN RDMB)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	GLY A 208 GLY A 180 GLY A 181 LEU A 206 ASN A 213	ANP A 602 (-3.3A) ANP A 602 (-3.4A) ANP A 602 (-3.5A) None None	0.85A	1xdsB-5obuA: undetectable	1xdsB-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 7	LEU A 392 PHE A 457 ARG A 437 LEU A 522	None	1.01A	2eikA-5obuA: undetectable 2eikJ-5obuA: undetectable	2eikA-5obuA: undetectable 2eikJ-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_B_SAMB500_0 (HYPOTHETICAL PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASP A 177 VAL A 320 PRO A 126 THR A 124	MG A 601 ( 4.9A) None None None	1.26A	2q6oB-5obuA: undetectable	2q6oB-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RCT_A_RTLA140_1 (RETINOL-BINDING PROTEIN II, CELLULAR)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	3 / 3	GLN A 330 THR A 296 TRP A 211	None	1.16A	2rctA-5obuA: undetectable	2rctA-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BCR_A_AZZA940_1 (GLYCOGEN PHOSPHORYLASE, MUSCLE FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 5	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.12A	3bcrA-5obuA: 2.0	3bcrA-5obuA: 7.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.09A	3dd1A-5obuA: undetectable	3dd1A-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.07A	3dd1B-5obuA: undetectable	3dd1B-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.07A	3ddsA-5obuA: undetectable	3ddsA-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.06A	3ddsB-5obuA: undetectable	3ddsB-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.09A	3ddwA-5obuA: undetectable	3ddwA-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 6	ASN A 130 PHE A 129 ALA A 132 GLY A 76	None	1.08A	3ddwB-5obuA: undetectable	3ddwB-5obuA: 6.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_A_SALA3005_1 (TRANSCRIPTIONAL REGULATOR TCAR)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 8	ASN A 153 THR A 156 LEU A 160 ALA A 356	None	0.94A	3kp6A-5obuA: undetectable	3kp6A-5obuA: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NK7_A_SAMA770_0 (23S RRNA METHYLTRANSFERASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 522 GLY A 387 ILE A 455 SER A 381 VAL A 420	None	1.05A	3nk7A-5obuA: undetectable	3nk7A-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P4W_B_DSFB319_1 (GLR4197 PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 9	ILE A 300 ILE A 304 VAL A 333 ILE A 314 ILE A 317	None	1.18A	3p4wB-5obuA: undetectable	3p4wB-5obuA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P4W_D_DSFD319_1 (GLR4197 PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 10	ILE A 300 ILE A 304 VAL A 333 ILE A 314 ILE A 317	None	1.17A	3p4wD-5obuA: undetectable	3p4wD-5obuA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P4W_E_DSFE319_1 (GLR4197 PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 10	ILE A 300 ILE A 304 VAL A 333 ILE A 314 ILE A 317	None	1.17A	3p4wE-5obuA: undetectable	3p4wE-5obuA: 13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UBO_B_ADNB353_1 (ADENOSINE KINASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	ASN A 204 GLY A 180 GLY A 181 SER A 70 ASP A 210	None ANP A 602 (-3.4A) ANP A 602 (-3.5A) None None	1.07A	3uboB-5obuA: undetectable	3uboB-5obuA: 12.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VT3_A_VDXA500_1 (VITAMIN D3 RECEPTOR)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 332 VAL A 333 SER A 335 VAL A 185 LEU A 187	None	1.30A	3vt3A-5obuA: undetectable	3vt3A-5obuA: 12.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VT7_A_VDXA500_1 (VITAMIN D3 RECEPTOR)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	LEU A 332 VAL A 333 SER A 335 VAL A 185 LEU A 187	None	1.30A	3vt7A-5obuA: undetectable	3vt7A-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K9C_B_ADNB401_1 (SUGAR KINASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	5 / 12	ASN A 204 GLY A 180 GLY A 181 SER A 70 ASP A 210	None ANP A 602 (-3.4A) ANP A 602 (-3.5A) None None	1.11A	4k9cB-5obuA: undetectable	4k9cB-5obuA: 10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MM4_B_8PRB603_2 (TRANSPORTER)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	3 / 3	SER A 301 MET A 336 ASP A 184	None	0.91A	4mm4B-5obuA: undetectable	4mm4B-5obuA: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWP_B_GCSB307_1 (CHITOSANASE)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 7	GLU A 154 THR A 15 GLY A 14 THR A 16	None ANP A 602 (-3.5A) ANP A 602 (-3.4A) ANP A 602 (-3.5A)	0.99A	4qwpB-5obuA: undetectable	4qwpB-5obuA: 13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WW7_A_ACTA303_0 (EKC/KEOPS COMPLEX SUBUNIT BUD32)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 4	LEU A 31 VAL A 30 GLU A 32 ARG A 38	None	1.26A	4ww7A-5obuA: undetectable	4ww7A-5obuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	6 / 10	GLY A 179 GLY A 208 LYS A 250 SER A 254 GLY A 322 SER A 323	ANP A 602 (-3.3A) ANP A 602 (-3.3A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A)	1.05A	5aqfA-5obuA: 47.5	5aqfA-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	6 / 10	GLY A 179 LYS A 250 SER A 254 GLY A 322 SER A 323 ARG A 325	ANP A 602 (-3.3A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A) None	1.08A	5aqfA-5obuA: 47.5	5aqfA-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	7 / 10	GLY A 180 GLY A 208 GLU A 247 LYS A 250 SER A 254 GLY A 322 SER A 323	ANP A 602 (-3.4A) ANP A 602 (-3.3A) ANP A 602 (-3.5A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A)	0.57A	5aqfA-5obuA: 47.5	5aqfA-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	6 / 10	GLY A 179 GLY A 208 LYS A 250 SER A 254 GLY A 322 SER A 323	ANP A 602 (-3.3A) ANP A 602 (-3.3A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A)	1.05A	5aqfC-5obuA: 47.3	5aqfC-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	6 / 10	GLY A 179 LYS A 250 SER A 254 GLY A 322 SER A 323 ARG A 325	ANP A 602 (-3.3A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A) None	1.10A	5aqfC-5obuA: 47.3	5aqfC-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	7 / 10	GLY A 180 GLY A 208 GLU A 247 LYS A 250 SER A 254 GLY A 322 SER A 323	ANP A 602 (-3.4A) ANP A 602 (-3.3A) ANP A 602 (-3.5A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A)	0.56A	5aqfC-5obuA: 47.3	5aqfC-5obuA: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	7 / 10	GLY A 179 GLY A 208 LYS A 250 SER A 254 GLY A 322 SER A 323 ARG A 325	ANP A 602 (-3.3A) ANP A 602 (-3.3A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A) None	1.09A	5aqyA-5obuA: 50.2	5aqyA-5obuA: 12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	7 / 10	GLY A 180 GLY A 208 GLU A 247 LYS A 250 SER A 254 GLY A 322 SER A 323	ANP A 602 (-3.4A) ANP A 602 (-3.3A) ANP A 602 (-3.5A) ANP A 602 (-2.8A) ANP A 602 (-2.7A) ANP A 602 (-3.2A) ANP A 602 (-3.6A)	0.58A	5aqyA-5obuA: 50.2	5aqyA-5obuA: 12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JNC_A_ACTA305_0 (CARBONIC ANHYDRASE 4)	5obu	CHAPERONE PROTEIN DNAK (Mycoplasma genitalium)	4 / 4	GLN A 359 VAL A 122 GLU A 149 ILE A 8	None	1.42A	5jncA-5obuA: undetectable	5jncA-5obuA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C8L_A_CFFA940_1","PROTEIN (GLYCOGEN PHOSPHORYLASE)","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.11A","1c8lA-5obuA:undetectable","1c8lA-5obuA:7.53"],["1FBM_B_RTLB951_1","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"THR A 267;LEU A 266;VAL A 276;LEU A 278","None","1.09A","1fbmB-5obuA:undetectable","1fbmB-5obuA:undetectable"],["1FK6_A_LNLA1201_1","NON-SPECIFIC LIPID TRANSFER PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ASN A 231;ALA A 238;LEU A 242;ALA A 246;ILE A 216","None","0.76A","1fk6A-5obuA:undetectable","1fk6A-5obuA:25.26"],["1GFZ_A_CFFA940_1","GLYCOGEN PHOSPHORYLASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.07A","1gfzA-5obuA:undetectable","1gfzA-5obuA:7.53"],["1L5Q_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.08A","1l5qA-5obuA:undetectable","1l5qA-5obuA:7.12"],["1L5Q_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.07A","1l5qB-5obuA:undetectable","1l5qB-5obuA:7.12"],["1L7X_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.03A","1l7xA-5obuA:undetectable","1l7xA-5obuA:7.12"],["1L7X_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.07A","1l7xB-5obuA:undetectable","1l7xB-5obuA:7.12"],["1QZZ_A_SAMA635_0","ACLACINOMYCIN-10-HYDROXYLASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"GLY A 208;GLY A 180;GLY A 181;LEU A 206;ASN A 213","ANP A 602 (-3.3A);ANP A 602 (-3.4A);ANP A 602 (-3.5A);None;None","0.83A","1qzzA-5obuA:2.4","1qzzA-5obuA:undetectable"],["1RK3_A_VDXA500_1","VITAMIN D3 RECEPTOR","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 332;VAL A 333;SER A 335;VAL A 185;LEU A 187","None","1.26A","1rk3A-5obuA:undetectable","1rk3A-5obuA:12.55"],["1S9P_A_DESA459_1","ESTROGEN-RELATED RECEPTOR GAMMA","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 103;LEU A 106;ALA A 110;LEU A  31;ILE A 123","None","1.02A","1s9pA-5obuA:undetectable","1s9pA-5obuA:17.88"],["1S9P_D_DESD600_1","ESTROGEN-RELATED RECEPTOR GAMMA","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 103;LEU A 106;ALA A 110;LEU A  31;ILE A 123","None","1.04A","1s9pD-5obuA:undetectable","1s9pD-5obuA:17.88"],["1UWJ_B_BAXB1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",3,"ILE A 453;ASP A 418;PHE A 438","None","0.66A","1uwjB-5obuA:undetectable","1uwjB-5obuA:14.49"],["1X7P_B_SAMB302_0","RRNA METHYLTRANSFERASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ASP A 471;GLY A 441;GLY A 442;ILE A 455;LEU A 522","None","1.16A","1x7pA-5obuA:undetectable;1x7pB-5obuA:undetectable","1x7pA-5obuA:undetectable;1x7pB-5obuA:undetectable"],["1XDS_A_SAMA5635_0","PROTEIN RDMB","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"GLY A 208;GLY A 180;GLY A 181;LEU A 206;ASN A 213","ANP A 602 (-3.3A);ANP A 602 (-3.4A);ANP A 602 (-3.5A);None;None","0.91A","1xdsA-5obuA:undetectable","1xdsA-5obuA:undetectable"],["1XDS_B_SAMB9635_0","PROTEIN RDMB","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"GLY A 208;GLY A 180;GLY A 181;LEU A 206;ASN A 213","ANP A 602 (-3.3A);ANP A 602 (-3.4A);ANP A 602 (-3.5A);None;None","0.85A","1xdsB-5obuA:undetectable","1xdsB-5obuA:undetectable"],["2EIK_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"LEU A 392;PHE A 457;ARG A 437;LEU A 522","None","1.01A","2eikA-5obuA:undetectable;2eikJ-5obuA:undetectable","2eikA-5obuA:undetectable;2eikJ-5obuA:undetectable"],["2Q6O_B_SAMB500_0","HYPOTHETICAL PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASP A 177;VAL A 320;PRO A 126;THR A 124"," MG A 601 ( 4.9A);None;None;None","1.26A","2q6oB-5obuA:undetectable","2q6oB-5obuA:undetectable"],["2RCT_A_RTLA140_1","RETINOL-BINDING PROTEIN II, CELLULAR","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",3,"GLN A 330;THR A 296;TRP A 211","None","1.16A","2rctA-5obuA:undetectable","2rctA-5obuA:undetectable"],["3BCR_A_AZZA940_1","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.12A","3bcrA-5obuA:2.0","3bcrA-5obuA:7.53"],["3DD1_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.09A","3dd1A-5obuA:undetectable","3dd1A-5obuA:6.87"],["3DD1_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.07A","3dd1B-5obuA:undetectable","3dd1B-5obuA:6.87"],["3DDS_A_CFFA904_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.07A","3ddsA-5obuA:undetectable","3ddsA-5obuA:6.87"],["3DDS_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.06A","3ddsB-5obuA:undetectable","3ddsB-5obuA:6.87"],["3DDW_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.09A","3ddwA-5obuA:undetectable","3ddwA-5obuA:6.87"],["3DDW_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 130;PHE A 129;ALA A 132;GLY A  76","None","1.08A","3ddwB-5obuA:undetectable","3ddwB-5obuA:6.87"],["3KP6_A_SALA3005_1","TRANSCRIPTIONAL REGULATOR TCAR","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"ASN A 153;THR A 156;LEU A 160;ALA A 356","None","0.94A","3kp6A-5obuA:undetectable","3kp6A-5obuA:21.19"],["3NK7_A_SAMA770_0","23S RRNA METHYLTRANSFERASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 522;GLY A 387;ILE A 455;SER A 381;VAL A 420","None","1.05A","3nk7A-5obuA:undetectable","3nk7A-5obuA:undetectable"],["3P4W_B_DSFB319_1","GLR4197 PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ILE A 300;ILE A 304;VAL A 333;ILE A 314;ILE A 317","None","1.18A","3p4wB-5obuA:undetectable","3p4wB-5obuA:13.74"],["3P4W_D_DSFD319_1","GLR4197 PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ILE A 300;ILE A 304;VAL A 333;ILE A 314;ILE A 317","None","1.17A","3p4wD-5obuA:undetectable","3p4wD-5obuA:13.74"],["3P4W_E_DSFE319_1","GLR4197 PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ILE A 300;ILE A 304;VAL A 333;ILE A 314;ILE A 317","None","1.17A","3p4wE-5obuA:undetectable","3p4wE-5obuA:13.74"],["3UBO_B_ADNB353_1","ADENOSINE KINASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ASN A 204;GLY A 180;GLY A 181;SER A  70;ASP A 210","None;ANP A 602 (-3.4A);ANP A 602 (-3.5A);None;None","1.07A","3uboB-5obuA:undetectable","3uboB-5obuA:12.43"],["3VT3_A_VDXA500_1","VITAMIN D3 RECEPTOR","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 332;VAL A 333;SER A 335;VAL A 185;LEU A 187","None","1.30A","3vt3A-5obuA:undetectable","3vt3A-5obuA:12.45"],["3VT7_A_VDXA500_1","VITAMIN D3 RECEPTOR","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"LEU A 332;VAL A 333;SER A 335;VAL A 185;LEU A 187","None","1.30A","3vt7A-5obuA:undetectable","3vt7A-5obuA:12.84"],["4K9C_B_ADNB401_1","SUGAR KINASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",5,"ASN A 204;GLY A 180;GLY A 181;SER A  70;ASP A 210","None;ANP A 602 (-3.4A);ANP A 602 (-3.5A);None;None","1.11A","4k9cB-5obuA:undetectable","4k9cB-5obuA:10.60"],["4MM4_B_8PRB603_2","TRANSPORTER","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",3,"SER A 301;MET A 336;ASP A 184","None","0.91A","4mm4B-5obuA:undetectable","4mm4B-5obuA:11.81"],["4QWP_B_GCSB307_1","CHITOSANASE","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"GLU A 154;THR A  15;GLY A  14;THR A  16","None;ANP A 602 (-3.5A);ANP A 602 (-3.4A);ANP A 602 (-3.5A)","0.99A","4qwpB-5obuA:undetectable","4qwpB-5obuA:13.71"],["4WW7_A_ACTA303_0","EKC\/KEOPS COMPLEX SUBUNIT BUD32","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"LEU A  31;VAL A  30;GLU A  32;ARG A  38","None","1.26A","4ww7A-5obuA:undetectable","4ww7A-5obuA:undetectable"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",6,"GLY A 179;GLY A 208;LYS A 250;SER A 254;GLY A 322;SER A 323","ANP A 602 (-3.3A);ANP A 602 (-3.3A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A)","1.05A","5aqfA-5obuA:47.5","5aqfA-5obuA:12.84"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",6,"GLY A 179;LYS A 250;SER A 254;GLY A 322;SER A 323;ARG A 325","ANP A 602 (-3.3A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A);None","1.08A","5aqfA-5obuA:47.5","5aqfA-5obuA:12.84"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",7,"GLY A 180;GLY A 208;GLU A 247;LYS A 250;SER A 254;GLY A 322;SER A 323","ANP A 602 (-3.4A);ANP A 602 (-3.3A);ANP A 602 (-3.5A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A)","0.57A","5aqfA-5obuA:47.5","5aqfA-5obuA:12.84"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",6,"GLY A 179;GLY A 208;LYS A 250;SER A 254;GLY A 322;SER A 323","ANP A 602 (-3.3A);ANP A 602 (-3.3A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A)","1.05A","5aqfC-5obuA:47.3","5aqfC-5obuA:12.84"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",6,"GLY A 179;LYS A 250;SER A 254;GLY A 322;SER A 323;ARG A 325","ANP A 602 (-3.3A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A);None","1.10A","5aqfC-5obuA:47.3","5aqfC-5obuA:12.84"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",7,"GLY A 180;GLY A 208;GLU A 247;LYS A 250;SER A 254;GLY A 322;SER A 323","ANP A 602 (-3.4A);ANP A 602 (-3.3A);ANP A 602 (-3.5A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A)","0.56A","5aqfC-5obuA:47.3","5aqfC-5obuA:12.84"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",7,"GLY A 179;GLY A 208;LYS A 250;SER A 254;GLY A 322;SER A 323;ARG A 325","ANP A 602 (-3.3A);ANP A 602 (-3.3A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A);None","1.09A","5aqyA-5obuA:50.2","5aqyA-5obuA:12.02"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",7,"GLY A 180;GLY A 208;GLU A 247;LYS A 250;SER A 254;GLY A 322;SER A 323","ANP A 602 (-3.4A);ANP A 602 (-3.3A);ANP A 602 (-3.5A);ANP A 602 (-2.8A);ANP A 602 (-2.7A);ANP A 602 (-3.2A);ANP A 602 (-3.6A)","0.58A","5aqyA-5obuA:50.2","5aqyA-5obuA:12.02"],["5JNC_A_ACTA305_0","CARBONIC ANHYDRASE 4","5obu","CHAPERONE PROTEIN DNAK","Mycoplasma genitalium",4,"GLN A 359;VAL A 122;GLU A 149;ILE A   8","None","1.42A","5jncA-5obuA:undetectable","5jncA-5obuA:undetectable"]]